Hero image for fda mflusiva decision 2026

FDA Decision on Moderna's mFLUSIVA (mRNA-1010) Flu Vaccine

scheduled · milestone · America/New_York

The FDA's Prescription Drug User Fee Act (PDUFA) goal date for Moderna's mRNA-1010 seasonal influenza vaccine, branded mFLUSIVA, is Wednesday, August 5, 2026. The FDA's Vaccines and Related Biological Products Advisory Committee voted 9–0 in favor of the vaccine on June 18, 2026. PDUFA dates are goal dates, not guarantees — the FDA occasionally misses them by days to months.

Source: https://www.morningstar.com/news/accesswire/1138398msn/moderna-announces-the-us-food-and-drug-administration-will-initiate-the-review-of-its-investigational-seasonal-influenza-vaccine-submission

Predictions

Will the FDA approve Moderna's mFLUSIVA (mRNA-1010) seasonal influenza vaccine by its PDUFA goal date of Wednesday, August 5, 2026?
FDA Decision on Moderna's mFLUSIVA (mRNA-1010) Flu Vaccine · Closed · Closed 10m ago

Activity and Results views arrive in later slices.